parecoxib has been researched along with Cancer of Colon in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gilmer, JF; Kedziora, K; Kelleher, DP; Keogh, B; Maguire, J; Reilly, M; Ruiz, JF; Windle, H | 1 |
| Chang, WL; Chen, CH; Liu, YW; Lu, FJ; Peng, JY; Wong, CH | 1 |
| Dervenis, C; Kapota, E; Kostopanagiotou, G; Matsota, P; Pandazi, A; Paraskevopoulou, P | 1 |
| Bleichrodt, RP; Boerman, OC; Goldenberg, DM; Hendriks, T; Koppe, MJ; Oyen, WJ; Verhofstad, AA | 1 |
1 trial(s) available for parecoxib and Cancer of Colon
| Article | Year |
|---|---|
Preincisional versus postincisional administration of parecoxib in colorectal surgery: effect on postoperative pain control and cytokine response. A randomized clinical trial.
Topics: Aged; Analgesia, Patient-Controlled; Analgesics, Opioid; Colectomy; Colonic Neoplasms; Cyclooxygenase 2 Inhibitors; Cytokines; Double-Blind Method; Female; Humans; Isoxazoles; Male; Middle Aged; Morphine; Pain Measurement; Pain, Postoperative | 2010 |
3 other study(ies) available for parecoxib and Cancer of Colon
| Article | Year |
|---|---|
A double prodrug system for colon targeting of benzenesulfonamide COX-2 inhibitors.
Topics: Animals; Benzenesulfonamides; Caco-2 Cells; Celecoxib; Clostridium perfringens; Colon; Colonic Neoplasms; Cyclization; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Drug Design; Humans; NADH, NADPH Oxidoreductases; Nitroreductases; Prodrugs; Pyrazoles; Rats; Sulfonamides | 2011 |
Parecoxib expresses anti-metastasis effect through inhibition of epithelial-mesenchymal transition and the Wnt/β-catenin signaling pathway in human colon cancer DLD-1 cell line.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; beta Catenin; Cadherins; Cell Line; Cell Line, Tumor; Cell Movement; Colonic Neoplasms; Cyclooxygenase 2; Epithelial-Mesenchymal Transition; Glycogen Synthase Kinase 3 beta; Humans; Isoxazoles; Proto-Oncogene Proteins c-akt; Vimentin; Wnt Signaling Pathway | 2022 |
Combination therapy using the cyclooxygenase-2 inhibitor Parecoxib and radioimmunotherapy in nude mice with small peritoneal metastases of colonic origin.
Topics: Animals; Antibodies, Monoclonal; Carcinoma; Colonic Neoplasms; Cyclooxygenase Inhibitors; Iodine Radioisotopes; Isoxazoles; Male; Maximum Tolerated Dose; Mice; Mice, Inbred BALB C; Mice, Nude; Peritoneal Neoplasms; Radioimmunotherapy; Survival; Tissue Distribution; Transplantation, Heterologous | 2006 |